Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
13 12 Search
2026
Pharmacological Targets in Metabolic Diseases
2025
The gut microbiota-inflammation-HFpEF axis: deciphering the role of gut microbiota dysregulation in the pathogenesis and management of HFpEF
Frontiers in Cellular and Infection Microbiology
2025
Gut-Heart Axis: Microbiome Involvement in Restrictive Cardiomyopathies
Biomedicines
2025
Gut microbiota’s role in heart failure
Heart Failure Reviews
2025
Insights into the role of gut microbiota modulation in the management of various cardiovascular diseases: A new approach for improving the efficacy of current cardiovascular medications
European Journal of Pharmacology
2024
The impact of sodium-glucose cotransporter inhibitors on gut microbiota: a scoping review
Journal of Diabetes & Metabolic Disorders
2024
Exploring the mechanisms of chronic obstructive pulmonary disease and Crohn’s disease: a bioinformatics-based study
Scientific Reports
2024
20S-O-Glc-DM treats metabolic syndrome-induced heart failure through regulating gut flora
European Journal of Pharmacology
2023
Current Role of SLGT2 Inhibitors in the Management of the Whole Spectrum of Heart Failure: Focus on Dapagliflozin
Journal of Clinical Medicine
2023
Gut–Kidney–Heart: A Novel Trilogy
Biomedicines
2023
Effects and mechanisms of nutritional interventions on extradigestive complications in obese patients
World Journal of Gastrointestinal Surgery
2023
Pharmacomicrobiomics and Drug–Infection Interactions: The Impact of Commensal, Symbiotic and Pathogenic Microorganisms on a Host Response to Drug Therapy
International Journal of Molecular Sciences
Additional cited-by details will be shown when available from Crossref